VAM
EDIT icon

Verity Asset Management’s Editas Medicine EDIT Stock Holding History

Verity Asset Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,843
Closed -$245K – 231
2021
Q1 		$245K Buy
+5,843
New +$333K 0.15% 180

Other funds holding EDIT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Verity Asset Management's EDIT Position: Q2 2021 in Review

Verity Asset Management sold out of Editas Medicine (EDIT) in Q2 2021, closing a stake of 5,843 shares — an estimated $245K sold.

Verity Asset Management first reported a position in EDIT in Q1 2021 and held it in 1 quarter. The position peaked at $245K in Q1 2021. 313 funds tracked by Wall St. Rank hold EDIT as of Q2 2021.

  • Verity Asset Management reported no remaining Editas Medicine position as of Q2 2021 after selling out during the quarter.
  • Verity Asset Management sold 5,843 Editas Medicine shares in Q2 2021, an estimated $245K.
  • Verity Asset Management first reported a position in Editas Medicine in Q1 2021 and held it in 1 quarter.
  • Verity Asset Management's Editas Medicine position peaked at $245K in Q1 2021.
  • 313 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2021.

Based on Verity Asset Management's 13F filing for Q2 2021, filed 4 Aug 2021.